Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Wall Street in Fives - Must Read Lists for Friday » 16:34
09/17/21
09/17
16:34
09/17/21
16:34
TMO

Thermo Fisher

$596.98 /

+36.11 (+6.44%)

, FANG

Diamondback Energy

$82.56 /

+2.43 (+3.03%)

, X

U.S. Steel

$23.36 /

-2.03 (-8.00%)

, AMC

AMC Entertainment

$44.23 /

-1.82 (-3.95%)

, $ETH

Ethereum

/

+

, $BTC

Bitcoin

/

+

, BTC

Bitcoin

/

+

, BITCOIN

Bitcoin

/

+

, $LTC

Litecoin

/

+

, TTWO

Take-Two

$151.79 /

-0.1 (-0.07%)

, ACCD

Accolade

$45.35 /

+0.35 (+0.78%)

, LVS

Las Vegas Sands

$38.17 /

+0.66 (+1.76%)

, WYNN

Wynn Resorts

$83.30 /

-1.095 (-1.30%)

, FIVN

Five9

$175.22 /

+7.19 (+4.28%)

, ZM

Zoom Video

$287.58 /

+9.63 (+3.46%)

, IVZ

Invesco

$26.25 /

+1.37 (+5.51%)

, STT

State Street

$84.81 /

-2.195 (-2.52%)

, ZYME

Zymeworks

$35.62 /

-0.435 (-1.21%)

, UL

Unilever

$53.95 /

-0.585 (-1.07%)

, WFC

Wells Fargo

$46.46 /

+0.17 (+0.37%)

, DB

Deutsche Bank

$12.91 /

-0.21 (-1.60%)

, NOG

Northern Oil and Gas

$17.32 /

-1.12 (-6.07%)

, CRK

Comstock Resources

$8.66 /

-0.2 (-2.26%)

, IPHA

Innate Pharma

$8.07 /

+2.31 (+40.10%)

, AZN

AstraZeneca

$55.56 /

-1.04 (-1.84%)

, BGNE

BeiGene

$403.60 /

+18.32 (+4.75%)

, PTGX

Protagonist Therapeutics

$17.60 /

-28.53 (-61.85%)

, TCRR

TCR2 Therapeutics

$10.00 /

-5.715 (-36.38%)

, GRTS

Gritstone

$11.49 /

-2.015 (-14.93%)

, MANU

Manchester United

$18.00 /

+0.375 (+2.13%)

, CNI

Canadian National

$118.30 /

+2.45 (+2.11%)

, IFF

IFF

$135.21 /

-7.9 (-5.52%)

, PGR

Progressive

$92.64 /

-0.35 (-0.38%)

, MCFT

MasterCraft Boat

$25.60 /

+0.03 (+0.12%)

, PFE

Pfizer

$43.89 /

-0.57 (-1.28%)

, BNTX

BioNTech

$358.75 /

-13.75 (-3.69%)

Get caught up quickly on…

ShowHide Related Items >><<
ZYME Zymeworks
$35.62 /

-0.435 (-1.21%)

ZM Zoom Video
$287.58 /

+9.63 (+3.46%)

X U.S. Steel
$23.36 /

-2.03 (-8.00%)

WYNN Wynn Resorts
$83.30 /

-1.095 (-1.30%)

WFC Wells Fargo
$46.46 /

+0.17 (+0.37%)

UL Unilever
$53.95 /

-0.585 (-1.07%)

TTWO Take-Two
$151.79 /

-0.1 (-0.07%)

TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

TCRR TCR2 Therapeutics
$10.00 /

-5.715 (-36.38%)

STT State Street
$84.81 /

-2.195 (-2.52%)

PTGX Protagonist Therapeutics
$17.60 /

-28.53 (-61.85%)

PGR Progressive
$92.64 /

-0.35 (-0.38%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

NOG Northern Oil and Gas
$17.32 /

-1.12 (-6.07%)

MCFT MasterCraft Boat
$25.60 /

+0.03 (+0.12%)

MANU Manchester United
$18.00 /

+0.375 (+2.13%)

LVS Las Vegas Sands
$38.17 /

+0.66 (+1.76%)

IVZ Invesco
$26.25 /

+1.37 (+5.51%)

IPHA Innate Pharma
$8.07 /

+2.31 (+40.10%)

IFF IFF
$135.21 /

-7.9 (-5.52%)

GRTS Gritstone
$11.49 /

-2.015 (-14.93%)

FIVN Five9
$175.22 /

+7.19 (+4.28%)

FANG Diamondback Energy
$82.56 /

+2.43 (+3.03%)

DB Deutsche Bank
$12.91 /

-0.21 (-1.60%)

CNI Canadian National
$118.30 /

+2.45 (+2.11%)

BITCOIN Bitcoin
/

+

BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

AZN AstraZeneca
$55.56 /

-1.04 (-1.84%)

AMC AMC Entertainment
$44.23 /

-1.82 (-3.95%)

ACCD Accolade
$45.35 /

+0.35 (+0.78%)

$LTC Litecoin
/

+

$ETH Ethereum
/

+

$BTC Bitcoin
/

+

TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

08/04/21 Credit Suisse
Thermo Fisher assumed with an Outperform at Credit Suisse
08/04/21 Argus
Thermo Fisher price target raised to $600 from $530 at Argus
07/29/21 Cowen
Thermo Fisher price target raised to $560 from $525 at Cowen
07/29/21 BTIG
Thermo Fisher price target raised to $610 from $590 at BTIG
FANG Diamondback Energy
$82.56 /

+2.43 (+3.03%)

09/15/21 Truist
Diamondback Energy price target raised to $130 from $122 at Truist
07/22/21 Piper Sandler
Diamondback Energy price target raised to $112 from $102 at Piper Sandler
07/15/21 Mizuho
Diamondback Energy price target raised to $131 from $120 at Mizuho
07/07/21 Wells Fargo
Diamondback Energy price target raised to $101 from $90 at Wells Fargo
X U.S. Steel
$23.36 /

-2.03 (-8.00%)

09/15/21 Deutsche Bank
U.S. Steel price target raised to $50 from $38 at Deutsche Bank
07/07/21 Credit Suisse
Steel demand booming in the U.S., says Credit Suisse
07/01/21 Deutsche Bank
U.S. Steel price target raised to $38 from $30 at Deutsche Bank
06/16/21
Fly Intel: Top five analyst downgrades
AMC AMC Entertainment
$44.23 /

-1.82 (-3.95%)

09/01/21
Fly Intel: Top five analyst downgrades
09/01/21 Macquarie
AMC Entertainment downgraded to Underperform from Neutral at Macquarie
08/30/21 JPMorgan
Movie executives see 10% of screens closing, down from 15%, says JPMorgan
08/24/21 MKM Partners
Slow box office to make AMC Entertainment recovery difficult, says MKM Partners
$ETH Ethereum
/

+

05/07/21 Argus
Ethan Allen upgraded to Buy from Hold at Argus
05/07/21 Argus
Ethan Allen upgraded to Buy from Hold at Argus
11/24/20 UBS
RH price target raised to $450 from $380 at UBS
$BTC Bitcoin
/

+

09/08/21 Cowen
SEC's Coinbase action likely a broader crackdown on crypto lending, says Cowen
08/03/21 Craig-Hallum
Craig-Hallum bullish on Hut 8 Mining, initiates with a Buy
04/27/21 Roth Capital
Regulatory credits, bitcoin fuel Tesla Q1 headline beat, says Roth Capital
04/15/21 Morgan Stanley
WisdomTree Bitcoin ETP cross-listing could speed up growth, says Morgan Stanley
BTC Bitcoin
/

+

BITCOIN Bitcoin
/

+

05/13/21 BTIG
BTIG sees Binance news as 'net positive' for Coinbase
$LTC Litecoin
/

+

06/03/21 Mizuho
LTC Properties downgraded to Underperform from Neutral at Mizuho
03/30/21 Capital One
LTC Properties downgraded to Equalweight from Overweight at Capital One
03/03/21 RBC Capital
LTC Properties price target raised to $38 from $33 at RBC Capital
02/09/21 Mizuho
LTC Properties price target raised to $38 from $35 at Mizuho
TTWO Take-Two
$151.79 /

-0.1 (-0.07%)

09/17/21
Fly Intel: Top five analyst downgrades
09/17/21 BMO Capital
Take-Two downgraded to Market Perform from Outperform at BMO Capital
09/14/21 Ascendiant
Take-Two price target lowered to $198 from $216 at Ascendiant
09/13/21 JPMorgan
Activision should be bought on China regulation concerns, says JPMorgan
ACCD Accolade
$45.35 /

+0.35 (+0.78%)

09/17/21
Fly Intel: Top five analyst upgrades
09/17/21 Baird
Baird upgrades Accolade to Outperform on execution, valuation discount
09/17/21 Baird
Accolade upgraded to Outperform from Neutral at Baird
07/13/21 Baird
Accolade price target raised to $58 from $54 at Baird
LVS Las Vegas Sands
$38.17 /

+0.66 (+1.76%)

09/17/21 Jefferies
Jefferies downgrades Las Vegas Sands on 'growth uncertainty' in Macau
09/17/21 Jefferies
Las Vegas Sands downgraded to Hold from Buy at Jefferies
09/16/21 JPMorgan
JPMorgan downgrades Las Vegas Sands on Macau uncertainty
WYNN Wynn Resorts
$83.30 /

-1.095 (-1.30%)

09/17/21 Argus
Wynn Resorts downgraded to Hold from Buy at Argus
09/17/21 Argus
Wynn Resorts downgraded to Hold from Buy at Argus
09/16/21 JPMorgan
Wynn Resorts downgraded on Macau uncertainty at JPMorgan
FIVN Five9
$175.22 /

+7.19 (+4.28%)

09/17/21 Piper Sandler
Piper upgrades Five9 on potential for increased Zoom takeover bid
09/17/21 Piper Sandler
Five9 upgraded to Overweight from Neutral at Piper Sandler
09/09/21 JMP Securities
Nice price target raised to $343 from $302 at JMP Securities
09/07/21 Needham
Five9 upgraded to Buy from Hold at Needham
ZM Zoom Video
$287.58 /

+9.63 (+3.46%)

09/03/21 UBS
DocuSign price target raised to $350 from $340 at UBS
IVZ Invesco
$26.25 /

+1.37 (+5.51%)

09/17/21 Deutsche Bank
State Street, Invesco deal would be 'strategically compelling,' says Deutsche
09/17/21 Citi
Citi doubts State Street will buy Invesco outright, expects share pullback
07/12/21 Deutsche Bank
Invesco price target raised to $35 from $33 at Deutsche Bank
07/12/21 Citi
Invesco upgraded to Buy from Neutral at Citi
STT State Street
$84.81 /

-2.195 (-2.52%)

09/09/21 JPMorgan
JPMorgan expects 'sizable equity issue' from State Street after deal
09/08/21 Jefferies
State Street pullback on BBH deal a buying opportunity, says Jefferies
ZYME Zymeworks
$35.62 /

-0.435 (-1.21%)

09/13/21 Raymond James
Zymeworks data continue to outperform Herceptin, says Raymond James
08/05/21 H.C. Wainwright
Zymeworks price target lowered to $44 from $55 at H.C. Wainwright
03/30/21 Credit Suisse
Zymeworks initiated with an Outperform at Credit Suisse
03/30/21 Credit Suisse
Zymeworks initiated with an Outperform at Credit Suisse
UL Unilever
$53.95 /

-0.585 (-1.07%)

09/16/21 Deutsche Bank
Unilever downgraded to Hold from Buy at Deutsche Bank
09/02/21
Fly Intel: Top five analyst downgrades
09/02/21 JPMorgan
Unilever downgraded to Underweight from Neutral at JPMorgan
08/06/21 Morgan Stanley
Unilever upgraded to Equal Weight from Underweight at Morgan Stanley
WFC Wells Fargo
$46.46 /

+0.17 (+0.37%)

09/16/21 JPMorgan
JPMorgan does not expect Wells Fargo to be broken up
09/10/21 JPMorgan
Wells Fargo OCC fine 'moderate and manageable,' says JPMorgan
09/10/21 Morgan Stanley
Wells Fargo fine 'much lower' than Street baked in, says Morgan Stanley
09/01/21 Morgan Stanley
Morgan Stanley says Wells already warned investors more penalties could come
DB Deutsche Bank
$12.91 /

-0.21 (-1.60%)

09/17/21 JPMorgan
Deutsche Bank price target raised to EUR 13.50 from EUR 13 at JPMorgan
08/13/21
Fly Intel: Top five analyst upgrades
08/13/21 Keefe Bruyette
Deutsche Bank upgraded to Market Perform from Underperform at Keefe Bruyette
07/29/21 Credit Suisse
Deutsche Bank price target raised to EUR 10.50 from EUR 10 at Credit Suisse
NOG Northern Oil and Gas
$17.32 /

-1.12 (-6.07%)

09/01/21 Raymond James
Northern Oil and Gas price target raised to $32 at Raymond James
07/22/21 Piper Sandler
Northern Oil and Gas upgraded to Overweight from Neutral at Piper Sandler
07/01/21 Truist
Northern Oil and Gas price target raised to $33 from $25 at Truist
06/23/21 Piper Sandler
Northern Oil and Gas initiated with a Neutral at Piper Sandler
CRK Comstock Resources
$8.66 /

-0.2 (-2.26%)

07/15/21 Mizuho
Comstock Resources price target raised to $10 from $8 at Mizuho
07/13/21 Mizuho
Comstock Resources price target raised to $10 from $8 at Mizuho
04/20/21 Mizuho
Comstock Resources price target lowered to $8 from $9 at Mizuho
03/23/21 Citi
Comstock Resources price target lowered to $7 from $8 at Citi
IPHA Innate Pharma
$8.07 /

+2.31 (+40.10%)

09/17/21 Evercore ISI
Innate Pharma price target raised to $10 from $6 at Evercore ISI
09/02/21 SVB Leerink
SVB Leerink 'encouraged' by Innate's COAST update, upgrades to Outperform
09/02/21 SVB Leerink
Innate Pharma upgraded to Outperform from Market Perform at SVB Leerink
12/15/20
Fly Intel: Top five analyst downgrades
AZN AstraZeneca
$55.56 /

-1.04 (-1.84%)

09/17/21 Morgan Stanley
AstraZeneca price target raised to 10,000 GBp from 9,800 GBp at Morgan Stanley
09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
08/12/21 JPMorgan
AstraZeneca resumed with an Overweight at JPMorgan
BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

06/14/21 SVB Leerink
BeiGene price target raised to $417 from $388 at SVB Leerink
03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
PTGX Protagonist Therapeutics
$17.60 /

-28.53 (-61.85%)

09/17/21 Piper Sandler
Protagonist selloff 'overdone' following clinical hold, says Piper Sandler
09/17/21 Piper Sandler
Protagonist clinical hold brings more questions than answers, says Piper Sandler
08/06/21 H.C. Wainwright
Protagonist Therapeutics price target raised to $60 from $50 at H.C. Wainwright
08/05/21 SVB Leerink
Protagonist Therapeutics price target raised to $50 from $41 at SVB Leerink
TCRR TCR2 Therapeutics
$10.00 /

-5.715 (-36.38%)

09/17/21 Wedbush
TCR2 Therapeutics downgraded to Neutral from Outperform at Wedbush
08/06/21 BMO Capital
TCR2 Therapeutics price target lowered to $44 from $53 at BMO Capital
06/24/21 Goldman Sachs
TCR2 Therapeutics initiated with a Buy at Goldman Sachs
06/11/21 BMO Capital
TCR2 Therapeutics coverage transferred at BMO Capital
GRTS Gritstone
$11.49 /

-2.015 (-14.93%)

01/21/21 BTIG
Gritstone Oncology price target raised to $35 from $17 at BTIG
01/20/21 H.C. Wainwright
Gritstone Oncology price target raised to $24 from $16 at H.C. Wainwright
01/20/21 Baird
Gritstone Oncology downgraded to Underperform from Outperform at Baird
MANU Manchester United
$18.00 /

+0.375 (+2.13%)

04/06/21 Deutsche Bank
Manchester United price target raised to $17 from $16 at Deutsche Bank
CNI Canadian National
$118.30 /

+2.45 (+2.11%)

09/17/21 RBC Capital
Canadian National reinstated at Outperform from Sector Perform at RBC Capital
09/16/21 National Bank
Canadian National price target raised to C$144 from C$139 at National Bank
09/15/21 Wolfe Research
Kansas City Southern downgraded to Peer Perform from Outperform at Wolfe Research
09/14/21 TD Securities
Canadian National downgraded to Hold from Buy at TD Securities
IFF IFF
$135.21 /

-7.9 (-5.52%)

07/20/21 Redburn
IFF initiated with a Buy at Redburn
06/28/21 Wells Fargo
IFF price target raised to $168 from $160 at Wells Fargo
05/13/21 Jefferies
IFF price target raised to $160 from $155 at Jefferies
05/12/21 Wells Fargo
IFF price target raised to $160 from $155 at Wells Fargo
PGR Progressive
$92.64 /

-0.35 (-0.38%)

08/17/21 Evercore ISI
Progressive added to 'Tactical Underperform List' at Evercore ISI
08/16/21 Wolfe Research
Progressive initiated with an Underperform at Wolfe Research
07/16/21 Barclays
Progressive price target lowered to $84 from $86 at Barclays
07/09/21 BofA
Progressive added to US 1 List; Arch Capital removed at BofA
MCFT MasterCraft Boat
$25.60 /

+0.03 (+0.12%)

09/02/21 Baird
MasterCraft Boat trading at 'absurd valuation,' says Baird
06/17/21 Truist
MasterCraft Boat price target lowered to $28 from $32 at Truist
05/13/21 Truist
MasterCraft Boat price target raised to $32 from $26 at Truist
05/13/21 B. Riley
MasterCraft Boat price target raised to $45 from $40 at B. Riley
PFE Pfizer
$43.89 /

-0.57 (-1.28%)

09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
09/16/21 Canaccord
Exact Sciences salesforce expansion a net positive, says Canaccord
09/16/21 BofA
Moderna boosters already reflected in 'bullish' consensus, says BofA
09/15/21 Raymond James
Exact Sciences' 'opportunistic' hires should boost sales, says Raymond James
BNTX BioNTech
$358.75 /

-13.75 (-3.69%)

08/27/21 UBS
BioNTech price target raised to $300 from $111 at UBS
08/20/21 Canaccord
BioNTech price target raised to $450 from $240 at Canaccord
08/12/21 Wells Fargo
Wells says Moderna vaccine looks more effective than Pfizer's against Delta
ZYME Zymeworks
$35.62 /

-0.435 (-1.21%)

ZM Zoom Video
$287.58 /

+9.63 (+3.46%)

X U.S. Steel
$23.36 /

-2.03 (-8.00%)

WYNN Wynn Resorts
$83.30 /

-1.095 (-1.30%)

WFC Wells Fargo
$46.46 /

+0.17 (+0.37%)

TTWO Take-Two
$151.79 /

-0.1 (-0.07%)

TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

TCRR TCR2 Therapeutics
$10.00 /

-5.715 (-36.38%)

STT State Street
$84.81 /

-2.195 (-2.52%)

PTGX Protagonist Therapeutics
$17.60 /

-28.53 (-61.85%)

PGR Progressive
$92.64 /

-0.35 (-0.38%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

NOG Northern Oil and Gas
$17.32 /

-1.12 (-6.07%)

MCFT MasterCraft Boat
$25.60 /

+0.03 (+0.12%)

MANU Manchester United
$18.00 /

+0.375 (+2.13%)

LVS Las Vegas Sands
$38.17 /

+0.66 (+1.76%)

IVZ Invesco
$26.25 /

+1.37 (+5.51%)

IFF IFF
$135.21 /

-7.9 (-5.52%)

GRTS Gritstone
$11.49 /

-2.015 (-14.93%)

FIVN Five9
$175.22 /

+7.19 (+4.28%)

FANG Diamondback Energy
$82.56 /

+2.43 (+3.03%)

DB Deutsche Bank
$12.91 /

-0.21 (-1.60%)

CRK Comstock Resources
$8.66 /

-0.2 (-2.26%)

CNI Canadian National
$118.30 /

+2.45 (+2.11%)

BNTX BioNTech
$358.75 /

-13.75 (-3.69%)

BITCOIN Bitcoin
/

+

BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

AZN AstraZeneca
$55.56 /

-1.04 (-1.84%)

AMC AMC Entertainment
$44.23 /

-1.82 (-3.95%)

ACCD Accolade
$45.35 /

+0.35 (+0.78%)

$LTC Litecoin
/

+

$ETH Ethereum
/

+

$BTC Bitcoin
/

+

  • 10
    Sep
  • 17
    Jun
  • 16
    Jun
  • 04
    Jun
  • 12
    Mar
  • 09
    Feb
  • 05
    Feb
  • 03
    Feb
  • 20
    Jan
  • 13
    Jan
  • 11
    Dec
  • 02
    Dec
  • 22
    Oct
ZYME Zymeworks
$35.62 /

-0.435 (-1.21%)

ZM Zoom Video
$287.58 /

+9.63 (+3.46%)

X U.S. Steel
$23.36 /

-2.03 (-8.00%)

WYNN Wynn Resorts
$83.30 /

-1.095 (-1.30%)

WFC Wells Fargo
$46.46 /

+0.17 (+0.37%)

UL Unilever
$53.95 /

-0.585 (-1.07%)

TTWO Take-Two
$151.79 /

-0.1 (-0.07%)

TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

STT State Street
$84.81 /

-2.195 (-2.52%)

PGR Progressive
$92.64 /

-0.35 (-0.38%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

NOG Northern Oil and Gas
$17.32 /

-1.12 (-6.07%)

MANU Manchester United
$18.00 /

+0.375 (+2.13%)

LVS Las Vegas Sands
$38.17 /

+0.66 (+1.76%)

IVZ Invesco
$26.25 /

+1.37 (+5.51%)

FIVN Five9
$175.22 /

+7.19 (+4.28%)

DB Deutsche Bank
$12.91 /

-0.21 (-1.60%)

CNI Canadian National
$118.30 /

+2.45 (+2.11%)

BITCOIN Bitcoin
/

+

BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

AZN AstraZeneca
$55.56 /

-1.04 (-1.84%)

AMC AMC Entertainment
$44.23 /

-1.82 (-3.95%)

$LTC Litecoin
/

+

$ETH Ethereum
/

+

$BTC Bitcoin
/

+

ZM Zoom Video
$287.58 /

+9.63 (+3.46%)

X U.S. Steel
$23.36 /

-2.03 (-8.00%)

WFC Wells Fargo
$46.46 /

+0.17 (+0.37%)

UL Unilever
$53.95 /

-0.585 (-1.07%)

TTWO Take-Two
$151.79 /

-0.1 (-0.07%)

TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

PGR Progressive
$92.64 /

-0.35 (-0.38%)

MANU Manchester United
$18.00 /

+0.375 (+2.13%)

LVS Las Vegas Sands
$38.17 /

+0.66 (+1.76%)

FIVN Five9
$175.22 /

+7.19 (+4.28%)

FANG Diamondback Energy
$82.56 /

+2.43 (+3.03%)

DB Deutsche Bank
$12.91 /

-0.21 (-1.60%)

CRK Comstock Resources
$8.66 /

-0.2 (-2.26%)

CNI Canadian National
$118.30 /

+2.45 (+2.11%)

AZN AstraZeneca
$55.56 /

-1.04 (-1.84%)

AMC AMC Entertainment
$44.23 /

-1.82 (-3.95%)

ACCD Accolade
$45.35 /

+0.35 (+0.78%)

$LTC Litecoin
/

+

$ETH Ethereum
/

+

ZM Zoom Video
$287.58 /

+9.63 (+3.46%)

X U.S. Steel
$23.36 /

-2.03 (-8.00%)

WYNN Wynn Resorts
$83.30 /

-1.095 (-1.30%)

WFC Wells Fargo
$46.46 /

+0.17 (+0.37%)

TTWO Take-Two
$151.79 /

-0.1 (-0.07%)

TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

STT State Street
$84.81 /

-2.195 (-2.52%)

PGR Progressive
$92.64 /

-0.35 (-0.38%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

MANU Manchester United
$18.00 /

+0.375 (+2.13%)

LVS Las Vegas Sands
$38.17 /

+0.66 (+1.76%)

IVZ Invesco
$26.25 /

+1.37 (+5.51%)

FANG Diamondback Energy
$82.56 /

+2.43 (+3.03%)

DB Deutsche Bank
$12.91 /

-0.21 (-1.60%)

CNI Canadian National
$118.30 /

+2.45 (+2.11%)

AZN AstraZeneca
$55.56 /

-1.04 (-1.84%)

AMC AMC Entertainment
$44.23 /

-1.82 (-3.95%)

ACCD Accolade
$45.35 /

+0.35 (+0.78%)

$ETH Ethereum
/

+

Recommendations
Innate Pharma price target raised to $10 from $6 at Evercore ISI » 15:02
09/17/21
09/17
15:02
09/17/21
15:02
IPHA

Innate Pharma

$7.77 /

+2.01 (+34.90%)

, AZN

AstraZeneca

$55.61 /

-0.99 (-1.75%)

Evercore ISI analyst…

Evercore ISI analyst Liisa Bayko raised the firm's price target on Innate Pharma (IPHA) to $10 from $6 and keeps an Outperform rating on the shares after partner AstraZeneca (AZN) presented results from the randomized COAST Phase 2 trial during the ESMO medical congress. Bayko noted this is the first time results from a controlled study for monalizumab have been reported and it showed a benefit on top of Astra's durvalumab alone on both PFS and ORR in stage 3 non-small cell lung cancer.

ShowHide Related Items >><<
IPHA Innate Pharma
$7.77 /

+2.01 (+34.90%)

AZN AstraZeneca
$55.61 /

-0.99 (-1.75%)

IPHA Innate Pharma
$7.77 /

+2.01 (+34.90%)

09/02/21 SVB Leerink
SVB Leerink 'encouraged' by Innate's COAST update, upgrades to Outperform
09/02/21 SVB Leerink
Innate Pharma upgraded to Outperform from Market Perform at SVB Leerink
12/15/20
Fly Intel: Top five analyst downgrades
12/15/20 SVB Leerink
Innate Pharma downgraded to Market Perform at SVB Leerink
AZN AstraZeneca
$55.61 /

-0.99 (-1.75%)

09/17/21 Morgan Stanley
AstraZeneca price target raised to 10,000 GBp from 9,800 GBp at Morgan Stanley
09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
08/12/21 JPMorgan
AstraZeneca resumed with an Overweight at JPMorgan
08/11/21 Goldman Sachs
FibroGen price target lowered to $16 from $22 at Goldman Sachs
AZN AstraZeneca
$55.61 /

-0.99 (-1.75%)

AZN AstraZeneca
$55.61 /

-0.99 (-1.75%)

IPHA Innate Pharma
$7.77 /

+2.01 (+34.90%)

AZN AstraZeneca
$55.61 /

-0.99 (-1.75%)

AZN AstraZeneca
$55.61 /

-0.99 (-1.75%)

On The Fly
Wall Street in Fives - Must Read Lists at Midday » 12:07
09/17/21
09/17
12:07
09/17/21
12:07
TMO

Thermo Fisher

$604.50 /

+43.63 (+7.78%)

, FANG

Diamondback Energy

$82.72 /

+2.59 (+3.23%)

, X

U.S. Steel

$23.48 /

-1.91 (-7.52%)

, FB

Facebook

$365.53 /

-7.56 (-2.03%)

, AMC

AMC Entertainment

$44.83 /

-1.215 (-2.64%)

, $ETH

Ethereum

/

+

, $BTC

Bitcoin

/

+

, BTC

Bitcoin

/

+

, BITCOIN

Bitcoin

/

+

, $LTC

Litecoin

/

+

, IVZ

Invesco

$26.37 /

+1.49 (+5.99%)

, STT

State Street

$85.14 /

-1.865 (-2.14%)

, ZYME

Zymeworks

$35.53 /

-0.525 (-1.46%)

, UL

Unilever

$54.01 /

-0.52 (-0.95%)

, BBY

Best Buy

$110.26 /

+0.68 (+0.62%)

, TGT

Target

$247.04 /

-0.05 (-0.02%)

, BJ

BJ's Wholesale

$59.21 /

+0.31 (+0.53%)

, WMT

Walmart

$145.58 /

+0.55 (+0.38%)

, MUFG

Mitsubishi UFJ

$5.82 /

-0.055 (-0.94%)

, MANU

Manchester United

$17.77 /

+0.15 (+0.85%)

, CNI

Canadian National

$118.89 /

+3.04 (+2.62%)

, IFF

IFF

$137.68 /

-5.43 (-3.79%)

, PGR

Progressive

$92.88 /

-0.11 (-0.12%)

, MCFT

MasterCraft Boat

$24.25 /

-1.32 (-5.16%)

, IPHA

Innate Pharma

$8.15 /

+2.39 (+41.49%)

, AZN

AstraZeneca

$55.44 /

-1.16 (-2.05%)

, BGNE

BeiGene

$400.08 /

+14.8 (+3.84%)

, PTGX

Protagonist Therapeutics

$16.22 /

-29.91 (-64.84%)

, TCRR

TCR2 Therapeutics

$10.75 /

-4.96 (-31.57%)

, GRTS

Gritstone

$11.79 /

-1.71 (-12.67%)

, TTWO

Take-Two

$150.52 /

-1.375 (-0.91%)

, ACCD

Accolade

$44.69 /

-0.31 (-0.69%)

, LVS

Las Vegas Sands

$37.74 /

+0.23 (+0.61%)

, WYNN

Wynn Resorts

$83.77 /

-0.625 (-0.74%)

, ZM

Zoom Video

$281.50 /

+3.55 (+1.28%)

, FIVN

Five9

$172.59 /

+4.56 (+2.71%)

Get caught up quickly on…

ShowHide Related Items >><<
ZYME Zymeworks
$35.53 /

-0.525 (-1.46%)

ZM Zoom Video
$281.50 /

+3.55 (+1.28%)

X U.S. Steel
$23.48 /

-1.91 (-7.52%)

WYNN Wynn Resorts
$83.77 /

-0.625 (-0.74%)

WMT Walmart
$145.58 /

+0.55 (+0.38%)

UL Unilever
$54.01 /

-0.52 (-0.95%)

TTWO Take-Two
$150.52 /

-1.375 (-0.91%)

TMO Thermo Fisher
$604.50 /

+43.63 (+7.78%)

TGT Target
$247.04 /

-0.05 (-0.02%)

TCRR TCR2 Therapeutics
$10.75 /

-4.96 (-31.57%)

STT State Street
$85.14 /

-1.865 (-2.14%)

PTGX Protagonist Therapeutics
$16.22 /

-29.91 (-64.84%)

PGR Progressive
$92.88 /

-0.11 (-0.12%)

MUFG Mitsubishi UFJ
$5.82 /

-0.055 (-0.94%)

MCFT MasterCraft Boat
$24.25 /

-1.32 (-5.16%)

MANU Manchester United
$17.77 /

+0.15 (+0.85%)

LVS Las Vegas Sands
$37.74 /

+0.23 (+0.61%)

IVZ Invesco
$26.37 /

+1.49 (+5.99%)

IPHA Innate Pharma
$8.15 /

+2.39 (+41.49%)

IFF IFF
$137.68 /

-5.43 (-3.79%)

GRTS Gritstone
$11.79 /

-1.71 (-12.67%)

FIVN Five9
$172.59 /

+4.56 (+2.71%)

FB Facebook
$365.53 /

-7.56 (-2.03%)

FANG Diamondback Energy
$82.72 /

+2.59 (+3.23%)

CNI Canadian National
$118.89 /

+3.04 (+2.62%)

BJ BJ's Wholesale
$59.21 /

+0.31 (+0.53%)

BITCOIN Bitcoin
/

+

BGNE BeiGene
$400.08 /

+14.8 (+3.84%)

BBY Best Buy
$110.26 /

+0.68 (+0.62%)

AZN AstraZeneca
$55.44 /

-1.16 (-2.05%)

AMC AMC Entertainment
$44.83 /

-1.215 (-2.64%)

ACCD Accolade
$44.69 /

-0.31 (-0.69%)

$LTC Litecoin
/

+

$ETH Ethereum
/

+

$BTC Bitcoin
/

+

TMO Thermo Fisher
$604.50 /

+43.63 (+7.78%)

08/04/21 Credit Suisse
Thermo Fisher assumed with an Outperform at Credit Suisse
08/04/21 Argus
Thermo Fisher price target raised to $600 from $530 at Argus
07/29/21 Cowen
Thermo Fisher price target raised to $560 from $525 at Cowen
07/29/21 BTIG
Thermo Fisher price target raised to $610 from $590 at BTIG
FANG Diamondback Energy
$82.72 /

+2.59 (+3.23%)

09/15/21 Truist
Diamondback Energy price target raised to $130 from $122 at Truist
07/22/21 Piper Sandler
Diamondback Energy price target raised to $112 from $102 at Piper Sandler
07/15/21 Mizuho
Diamondback Energy price target raised to $131 from $120 at Mizuho
07/07/21 Wells Fargo
Diamondback Energy price target raised to $101 from $90 at Wells Fargo
X U.S. Steel
$23.48 /

-1.91 (-7.52%)

09/15/21 Deutsche Bank
U.S. Steel price target raised to $50 from $38 at Deutsche Bank
07/07/21 Credit Suisse
Steel demand booming in the U.S., says Credit Suisse
07/01/21 Deutsche Bank
U.S. Steel price target raised to $38 from $30 at Deutsche Bank
06/16/21
Fly Intel: Top five analyst downgrades
FB Facebook
$365.53 /

-7.56 (-2.03%)

09/17/21 Jefferies
Facebook price target raised to $440 from $425 at Jefferies
09/13/21 Goldman Sachs
Facebook initiated with a Buy at Goldman Sachs
09/09/21 JPMorgan
Netflix, Uber added as top U.S. Internet picks at JPMorgan
09/09/21 HSBC
Facebook price target raised to $300 from $275 at HSBC
AMC AMC Entertainment
$44.83 /

-1.215 (-2.64%)

09/01/21
Fly Intel: Top five analyst downgrades
09/01/21 Macquarie
AMC Entertainment downgraded to Underperform from Neutral at Macquarie
08/30/21 JPMorgan
Movie executives see 10% of screens closing, down from 15%, says JPMorgan
08/24/21 MKM Partners
Slow box office to make AMC Entertainment recovery difficult, says MKM Partners
$ETH Ethereum
/

+

05/07/21 Argus
Ethan Allen upgraded to Buy from Hold at Argus
05/07/21 Argus
Ethan Allen upgraded to Buy from Hold at Argus
11/24/20 UBS
RH price target raised to $450 from $380 at UBS
$BTC Bitcoin
/

+

09/08/21 Cowen
SEC's Coinbase action likely a broader crackdown on crypto lending, says Cowen
08/03/21 Craig-Hallum
Craig-Hallum bullish on Hut 8 Mining, initiates with a Buy
04/27/21 Roth Capital
Regulatory credits, bitcoin fuel Tesla Q1 headline beat, says Roth Capital
04/15/21 Morgan Stanley
WisdomTree Bitcoin ETP cross-listing could speed up growth, says Morgan Stanley
BTC Bitcoin
/

+

BITCOIN Bitcoin
/

+

05/13/21 BTIG
BTIG sees Binance news as 'net positive' for Coinbase
$LTC Litecoin
/

+

06/03/21 Mizuho
LTC Properties downgraded to Underperform from Neutral at Mizuho
03/30/21 Capital One
LTC Properties downgraded to Equalweight from Overweight at Capital One
03/03/21 RBC Capital
LTC Properties price target raised to $38 from $33 at RBC Capital
02/09/21 Mizuho
LTC Properties price target raised to $38 from $35 at Mizuho
IVZ Invesco
$26.37 /

+1.49 (+5.99%)

09/17/21 Deutsche Bank
State Street, Invesco deal would be 'strategically compelling,' says Deutsche
09/17/21 Citi
Citi doubts State Street will buy Invesco outright, expects share pullback
07/12/21 Deutsche Bank
Invesco price target raised to $35 from $33 at Deutsche Bank
07/12/21 Citi
Invesco upgraded to Buy from Neutral at Citi
STT State Street
$85.14 /

-1.865 (-2.14%)

09/09/21 JPMorgan
JPMorgan expects 'sizable equity issue' from State Street after deal
09/08/21 Jefferies
State Street pullback on BBH deal a buying opportunity, says Jefferies
ZYME Zymeworks
$35.53 /

-0.525 (-1.46%)

09/13/21 Raymond James
Zymeworks data continue to outperform Herceptin, says Raymond James
08/05/21 H.C. Wainwright
Zymeworks price target lowered to $44 from $55 at H.C. Wainwright
03/30/21 Credit Suisse
Zymeworks initiated with an Outperform at Credit Suisse
03/30/21 Credit Suisse
Zymeworks initiated with an Outperform at Credit Suisse
UL Unilever
$54.01 /

-0.52 (-0.95%)

09/16/21 Deutsche Bank
Unilever downgraded to Hold from Buy at Deutsche Bank
09/02/21
Fly Intel: Top five analyst downgrades
09/02/21 JPMorgan
Unilever downgraded to Underweight from Neutral at JPMorgan
08/06/21 Morgan Stanley
Unilever upgraded to Equal Weight from Underweight at Morgan Stanley
BBY Best Buy
$110.26 /

+0.68 (+0.62%)

08/25/21 Wedbush
Best Buy price target raised to $130 from $125 at Wedbush
08/25/21 DA Davidson
Best Buy price target raised to $135 from $125 at DA Davidson
08/25/21 Wells Fargo
Best Buy price target raised to $125 from $120 at Wells Fargo
08/25/21 Jefferies
Best Buy price target raised to $145 from $136 at Jefferies
TGT Target
$247.04 /

-0.05 (-0.02%)

08/26/21 Tigress Financial
Target shares to hit $320 within 12 months, says Tigress Financial
08/19/21 Jefferies
Target price target raised to $260 from $235 at Jefferies
08/19/21 DA Davidson
Target price target raised to $285 from $240 at DA Davidson
08/19/21 MKM Partners
Target price target raised to $248 from $216 at MKM Partners
BJ BJ's Wholesale
$59.21 /

+0.31 (+0.53%)

08/23/21 Credit Suisse
BJ's Wholesale price target raised to $60 from $52 at Credit Suisse
08/20/21 Loop Capital
BJ's Wholesale price target raised to $60 from $55 at Loop Capital
08/20/21 DA Davidson
BJ's Wholesale price target raised to $60 from $53 at DA Davidson
08/20/21 MKM Partners
BJ's Wholesale price target raised to $48 from $41 at MKM Partners
WMT Walmart
$145.58 /

+0.55 (+0.38%)

08/30/21 Credit Suisse
Amazon deal could add 35%-40% to Affirm contribution profit, says Credit Suisse
08/27/21 Tigress Financial
Walmart valuation limits outperformance potential, says Tigress Financial
08/18/21 Cowen
Walmart price target raised to $175 from $170 at Cowen
08/18/21 DA Davidson
Walmart's Q2 results should support stock gains, says DA Davidson
MUFG Mitsubishi UFJ
$5.82 /

-0.055 (-0.94%)

02/18/21 Daiwa
Mitsubishi UFJ upgraded to Outperform from Neutral at Daiwa
01/13/21 Jefferies
Mitsubishi UFJ upgraded to Buy from Hold at Jefferies
12/14/20 JPMorgan
Mitsubishi UFJ reinstated with an Overweight at JPMorgan
MANU Manchester United
$17.77 /

+0.15 (+0.85%)

04/06/21 Deutsche Bank
Manchester United price target raised to $17 from $16 at Deutsche Bank
CNI Canadian National
$118.89 /

+3.04 (+2.62%)

09/17/21 RBC Capital
Canadian National reinstated at Outperform from Sector Perform at RBC Capital
09/16/21 National Bank
Canadian National price target raised to C$144 from C$139 at National Bank
09/15/21 Wolfe Research
Kansas City Southern downgraded to Peer Perform from Outperform at Wolfe Research
09/14/21 TD Securities
Canadian National downgraded to Hold from Buy at TD Securities
IFF IFF
$137.68 /

-5.43 (-3.79%)

07/20/21 Redburn
IFF initiated with a Buy at Redburn
06/28/21 Wells Fargo
IFF price target raised to $168 from $160 at Wells Fargo
05/13/21 Jefferies
IFF price target raised to $160 from $155 at Jefferies
05/12/21 Wells Fargo
IFF price target raised to $160 from $155 at Wells Fargo
PGR Progressive
$92.88 /

-0.11 (-0.12%)

08/17/21 Evercore ISI
Progressive added to 'Tactical Underperform List' at Evercore ISI
08/16/21 Wolfe Research
Progressive initiated with an Underperform at Wolfe Research
07/16/21 Barclays
Progressive price target lowered to $84 from $86 at Barclays
07/09/21 BofA
Progressive added to US 1 List; Arch Capital removed at BofA
MCFT MasterCraft Boat
$24.25 /

-1.32 (-5.16%)

09/02/21 Baird
MasterCraft Boat trading at 'absurd valuation,' says Baird
06/17/21 Truist
MasterCraft Boat price target lowered to $28 from $32 at Truist
05/13/21 Truist
MasterCraft Boat price target raised to $32 from $26 at Truist
05/13/21 B. Riley
MasterCraft Boat price target raised to $45 from $40 at B. Riley
IPHA Innate Pharma
$8.15 /

+2.39 (+41.49%)

09/02/21 SVB Leerink
SVB Leerink 'encouraged' by Innate's COAST update, upgrades to Outperform
09/02/21 SVB Leerink
Innate Pharma upgraded to Outperform from Market Perform at SVB Leerink
12/15/20
Fly Intel: Top five analyst downgrades
12/15/20 SVB Leerink
Innate Pharma downgraded to Market Perform at SVB Leerink
AZN AstraZeneca
$55.44 /

-1.16 (-2.05%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
08/12/21 JPMorgan
AstraZeneca resumed with an Overweight at JPMorgan
08/11/21 Goldman Sachs
FibroGen price target lowered to $16 from $22 at Goldman Sachs
08/09/21 Morgan Stanley
AstraZeneca resumed with an Overweight at Morgan Stanley
BGNE BeiGene
$400.08 /

+14.8 (+3.84%)

06/14/21 SVB Leerink
BeiGene price target raised to $417 from $388 at SVB Leerink
03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
PTGX Protagonist Therapeutics
$16.22 /

-29.91 (-64.84%)

09/17/21 Piper Sandler
Protagonist selloff 'overdone' following clinical hold, says Piper Sandler
09/17/21 Piper Sandler
Protagonist clinical hold brings more questions than answers, says Piper Sandler
08/06/21 H.C. Wainwright
Protagonist Therapeutics price target raised to $60 from $50 at H.C. Wainwright
08/05/21 SVB Leerink
Protagonist Therapeutics price target raised to $50 from $41 at SVB Leerink
TCRR TCR2 Therapeutics
$10.75 /

-4.96 (-31.57%)

08/06/21 BMO Capital
TCR2 Therapeutics price target lowered to $44 from $53 at BMO Capital
06/24/21 Goldman Sachs
TCR2 Therapeutics initiated with a Buy at Goldman Sachs
06/11/21 BMO Capital
TCR2 Therapeutics coverage transferred at BMO Capital
05/14/21 Wedbush
TCR2 Therapeutics price target lowered to $45 from $57 at Wedbush
GRTS Gritstone
$11.79 /

-1.71 (-12.67%)

01/21/21 BTIG
Gritstone Oncology price target raised to $35 from $17 at BTIG
01/20/21 H.C. Wainwright
Gritstone Oncology price target raised to $24 from $16 at H.C. Wainwright
01/20/21 Baird
Gritstone Oncology downgraded to Underperform from Outperform at Baird
TTWO Take-Two
$150.52 /

-1.375 (-0.91%)

09/17/21
Fly Intel: Top five analyst downgrades
09/17/21 BMO Capital
Take-Two downgraded to Market Perform from Outperform at BMO Capital
09/14/21 Ascendiant
Take-Two price target lowered to $198 from $216 at Ascendiant
09/13/21 JPMorgan
Activision should be bought on China regulation concerns, says JPMorgan
ACCD Accolade
$44.69 /

-0.31 (-0.69%)

09/17/21
Fly Intel: Top five analyst upgrades
09/17/21 Baird
Baird upgrades Accolade to Outperform on execution, valuation discount
09/17/21 Baird
Accolade upgraded to Outperform from Neutral at Baird
07/13/21 Baird
Accolade price target raised to $58 from $54 at Baird
LVS Las Vegas Sands
$37.74 /

+0.23 (+0.61%)

09/17/21 Jefferies
Jefferies downgrades Las Vegas Sands on 'growth uncertainty' in Macau
09/17/21 Jefferies
Las Vegas Sands downgraded to Hold from Buy at Jefferies
09/16/21 JPMorgan
JPMorgan downgrades Las Vegas Sands on Macau uncertainty
WYNN Wynn Resorts
$83.77 /

-0.625 (-0.74%)

09/17/21 Argus
Wynn Resorts downgraded to Hold from Buy at Argus
09/17/21 Argus
Wynn Resorts downgraded to Hold from Buy at Argus
09/16/21 JPMorgan
Wynn Resorts downgraded on Macau uncertainty at JPMorgan
ZM Zoom Video
$281.50 /

+3.55 (+1.28%)

09/17/21 Piper Sandler
Piper upgrades Five9 on potential for increased Zoom takeover bid
09/09/21 JMP Securities
Nice price target raised to $343 from $302 at JMP Securities
09/07/21 Needham
Five9 upgraded to Buy from Hold at Needham
09/03/21 UBS
DocuSign price target raised to $350 from $340 at UBS
FIVN Five9
$172.59 /

+4.56 (+2.71%)

09/17/21 Piper Sandler
Five9 upgraded to Overweight from Neutral at Piper Sandler
ZYME Zymeworks
$35.53 /

-0.525 (-1.46%)

ZM Zoom Video
$281.50 /

+3.55 (+1.28%)

X U.S. Steel
$23.48 /

-1.91 (-7.52%)

WYNN Wynn Resorts
$83.77 /

-0.625 (-0.74%)

WMT Walmart
$145.58 /

+0.55 (+0.38%)

TTWO Take-Two
$150.52 /

-1.375 (-0.91%)

TMO Thermo Fisher
$604.50 /

+43.63 (+7.78%)

TGT Target
$247.04 /

-0.05 (-0.02%)

TCRR TCR2 Therapeutics
$10.75 /

-4.96 (-31.57%)

STT State Street
$85.14 /

-1.865 (-2.14%)

PTGX Protagonist Therapeutics
$16.22 /

-29.91 (-64.84%)

PGR Progressive
$92.88 /

-0.11 (-0.12%)

MUFG Mitsubishi UFJ
$5.82 /

-0.055 (-0.94%)

MCFT MasterCraft Boat
$24.25 /

-1.32 (-5.16%)

MANU Manchester United
$17.77 /

+0.15 (+0.85%)

LVS Las Vegas Sands
$37.74 /

+0.23 (+0.61%)

IVZ Invesco
$26.37 /

+1.49 (+5.99%)

IFF IFF
$137.68 /

-5.43 (-3.79%)

GRTS Gritstone
$11.79 /

-1.71 (-12.67%)

FIVN Five9
$172.59 /

+4.56 (+2.71%)

FB Facebook
$365.53 /

-7.56 (-2.03%)

FANG Diamondback Energy
$82.72 /

+2.59 (+3.23%)

CNI Canadian National
$118.89 /

+3.04 (+2.62%)

BJ BJ's Wholesale
$59.21 /

+0.31 (+0.53%)

BITCOIN Bitcoin
/

+

BGNE BeiGene
$400.08 /

+14.8 (+3.84%)

BBY Best Buy
$110.26 /

+0.68 (+0.62%)

AZN AstraZeneca
$55.44 /

-1.16 (-2.05%)

AMC AMC Entertainment
$44.83 /

-1.215 (-2.64%)

ACCD Accolade
$44.69 /

-0.31 (-0.69%)

$LTC Litecoin
/

+

$ETH Ethereum
/

+

$BTC Bitcoin
/

+

  • 10
    Sep
  • 16
    Jun
  • 12
    Mar
  • 09
    Feb
  • 03
    Feb
  • 20
    Jan
  • 13
    Jan
  • 11
    Dec
  • 02
    Dec
  • 22
    Oct
ZYME Zymeworks
$35.53 /

-0.525 (-1.46%)

ZM Zoom Video
$281.50 /

+3.55 (+1.28%)

X U.S. Steel
$23.48 /

-1.91 (-7.52%)

WYNN Wynn Resorts
$83.77 /

-0.625 (-0.74%)

WMT Walmart
$145.58 /

+0.55 (+0.38%)

UL Unilever
$54.01 /

-0.52 (-0.95%)

TTWO Take-Two
$150.52 /

-1.375 (-0.91%)

TMO Thermo Fisher
$604.50 /

+43.63 (+7.78%)

TGT Target
$247.04 /

-0.05 (-0.02%)

STT State Street
$85.14 /

-1.865 (-2.14%)

PGR Progressive
$92.88 /

-0.11 (-0.12%)

MUFG Mitsubishi UFJ
$5.82 /

-0.055 (-0.94%)

MANU Manchester United
$17.77 /

+0.15 (+0.85%)

LVS Las Vegas Sands
$37.74 /

+0.23 (+0.61%)

IVZ Invesco
$26.37 /

+1.49 (+5.99%)

FB Facebook
$365.53 /

-7.56 (-2.03%)

CNI Canadian National
$118.89 /

+3.04 (+2.62%)

BITCOIN Bitcoin
/

+

BGNE BeiGene
$400.08 /

+14.8 (+3.84%)

BBY Best Buy
$110.26 /

+0.68 (+0.62%)

AZN AstraZeneca
$55.44 /

-1.16 (-2.05%)

AMC AMC Entertainment
$44.83 /

-1.215 (-2.64%)

$LTC Litecoin
/

+

$ETH Ethereum
/

+

$BTC Bitcoin
/

+

ZM Zoom Video
$281.50 /

+3.55 (+1.28%)

X U.S. Steel
$23.48 /

-1.91 (-7.52%)

WMT Walmart
$145.58 /

+0.55 (+0.38%)

UL Unilever
$54.01 /

-0.52 (-0.95%)

TTWO Take-Two
$150.52 /

-1.375 (-0.91%)

TMO Thermo Fisher
$604.50 /

+43.63 (+7.78%)

TGT Target
$247.04 /

-0.05 (-0.02%)

STT State Street
$85.14 /

-1.865 (-2.14%)

PGR Progressive
$92.88 /

-0.11 (-0.12%)

MANU Manchester United
$17.77 /

+0.15 (+0.85%)

LVS Las Vegas Sands
$37.74 /

+0.23 (+0.61%)

IVZ Invesco
$26.37 /

+1.49 (+5.99%)

FIVN Five9
$172.59 /

+4.56 (+2.71%)

FB Facebook
$365.53 /

-7.56 (-2.03%)

FANG Diamondback Energy
$82.72 /

+2.59 (+3.23%)

CNI Canadian National
$118.89 /

+3.04 (+2.62%)

BJ BJ's Wholesale
$59.21 /

+0.31 (+0.53%)

BBY Best Buy
$110.26 /

+0.68 (+0.62%)

AZN AstraZeneca
$55.44 /

-1.16 (-2.05%)

AMC AMC Entertainment
$44.83 /

-1.215 (-2.64%)

ACCD Accolade
$44.69 /

-0.31 (-0.69%)

$LTC Litecoin
/

+

$ETH Ethereum
/

+

ZM Zoom Video
$281.50 /

+3.55 (+1.28%)

X U.S. Steel
$23.48 /

-1.91 (-7.52%)

WYNN Wynn Resorts
$83.77 /

-0.625 (-0.74%)

WMT Walmart
$145.58 /

+0.55 (+0.38%)

TTWO Take-Two
$150.52 /

-1.375 (-0.91%)

TMO Thermo Fisher
$604.50 /

+43.63 (+7.78%)

TGT Target
$247.04 /

-0.05 (-0.02%)

STT State Street
$85.14 /

-1.865 (-2.14%)

PGR Progressive
$92.88 /

-0.11 (-0.12%)

LVS Las Vegas Sands
$37.74 /

+0.23 (+0.61%)

IVZ Invesco
$26.37 /

+1.49 (+5.99%)

FB Facebook
$365.53 /

-7.56 (-2.03%)

FANG Diamondback Energy
$82.72 /

+2.59 (+3.23%)

CNI Canadian National
$118.89 /

+3.04 (+2.62%)

BBY Best Buy
$110.26 /

+0.68 (+0.62%)

AZN AstraZeneca
$55.44 /

-1.16 (-2.05%)

AMC AMC Entertainment
$44.83 /

-1.215 (-2.64%)

ACCD Accolade
$44.69 /

-0.31 (-0.69%)

$ETH Ethereum
/

+

On The Fly
Fly Intel: Pre-market Movers » 08:53
09/17/21
09/17
08:53
09/17/21
08:53
IPHA

Innate Pharma

$5.76 /

+0.26 (+4.73%)

, ABCL

AbCellera

$19.80 /

+1.03 (+5.49%)

, IVZ

Invesco

$24.88 /

-0.67 (-2.62%)

, BGNE

BeiGene

$385.26 /

+10.94 (+2.92%)

, BPTS

Biophytis

$8.90 /

+0.05 (+0.56%)

, MANU

Manchester United

$17.65 /

+0.105 (+0.60%)

, PTGX

Protagonist Therapeutics

$45.96 /

-0.44 (-0.95%)

, OPAD

Offerpad Solutions

$20.17 /

+7.395 (+57.89%)

, TTWO

Take-Two

$151.89 /

-0.78 (-0.51%)

, STT

State Street

$87.03 /

-0.9 (-1.02%)

Check out this morning's…

ShowHide Related Items >><<
TTWO Take-Two
$151.89 /

-0.78 (-0.51%)

STT State Street
$87.03 /

-0.9 (-1.02%)

PTGX Protagonist Therapeutics
$45.96 /

-0.44 (-0.95%)

OPAD Offerpad Solutions
$20.17 /

+7.395 (+57.89%)

MANU Manchester United
$17.65 /

+0.105 (+0.60%)

IVZ Invesco
$24.88 /

-0.67 (-2.62%)

IPHA Innate Pharma
$5.76 /

+0.26 (+4.73%)

BPTS Biophytis
$8.90 /

+0.05 (+0.56%)

BGNE BeiGene
$385.26 /

+10.94 (+2.92%)

ABCL AbCellera
$19.80 /

+1.03 (+5.49%)

IPHA Innate Pharma
$5.76 /

+0.26 (+4.73%)

09/02/21 SVB Leerink
SVB Leerink 'encouraged' by Innate's COAST update, upgrades to Outperform
09/02/21 SVB Leerink
Innate Pharma upgraded to Outperform from Market Perform at SVB Leerink
12/15/20
Fly Intel: Top five analyst downgrades
12/15/20 SVB Leerink
Innate Pharma downgraded to Market Perform at SVB Leerink
ABCL AbCellera
$19.80 /

+1.03 (+5.49%)

06/11/21 BMO Capital
AbCellera coverage transferred at BMO Capital
03/30/21 SVB Leerink
AbCellera price target lowered to $45 from $52 at SVB Leerink
03/24/21 BMO Capital
AbCellera price target lowered to $59 from $61 at BMO Capital
02/08/21 SVB Leerink
AbCellera price target raised to $52 from $45 at SVB Leerink
IVZ Invesco
$24.88 /

-0.67 (-2.62%)

09/17/21 Deutsche Bank
State Street, Invesco deal would be 'strategically compelling,' says Deutsche
09/17/21 Citi
Citi doubts State Street will buy Invesco outright, expects share pullback
07/12/21 Deutsche Bank
Invesco price target raised to $35 from $33 at Deutsche Bank
07/12/21 Citi
Invesco upgraded to Buy from Neutral at Citi
BGNE BeiGene
$385.26 /

+10.94 (+2.92%)

06/14/21 SVB Leerink
BeiGene price target raised to $417 from $388 at SVB Leerink
03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
BPTS Biophytis
$8.90 /

+0.05 (+0.56%)

MANU Manchester United
$17.65 /

+0.105 (+0.60%)

04/06/21 Deutsche Bank
Manchester United price target raised to $17 from $16 at Deutsche Bank
PTGX Protagonist Therapeutics
$45.96 /

-0.44 (-0.95%)

08/06/21 H.C. Wainwright
Protagonist Therapeutics price target raised to $60 from $50 at H.C. Wainwright
08/05/21 SVB Leerink
Protagonist Therapeutics price target raised to $50 from $41 at SVB Leerink
07/30/21 Piper Sandler
Protagonist Therapeutics price target raised to $93 from $53 at Piper Sandler
06/18/21 H.C. Wainwright
Protagonist price target raised to $50 from $36 at H.C. Wainwright
OPAD Offerpad Solutions
$20.17 /

+7.395 (+57.89%)

TTWO Take-Two
$151.89 /

-0.78 (-0.51%)

09/17/21 BMO Capital
Take-Two downgraded to Market Perform from Outperform at BMO Capital
09/14/21 Ascendiant
Take-Two price target lowered to $198 from $216 at Ascendiant
09/13/21 JPMorgan
Activision should be bought on China regulation concerns, says JPMorgan
09/10/21 Truist
Apple will likely appeal ruling in Epic case, says Truist
STT State Street
$87.03 /

-0.9 (-1.02%)

09/09/21 JPMorgan
JPMorgan expects 'sizable equity issue' from State Street after deal
09/08/21 Jefferies
State Street pullback on BBH deal a buying opportunity, says Jefferies
TTWO Take-Two
$151.89 /

-0.78 (-0.51%)

STT State Street
$87.03 /

-0.9 (-1.02%)

PTGX Protagonist Therapeutics
$45.96 /

-0.44 (-0.95%)

MANU Manchester United
$17.65 /

+0.105 (+0.60%)

IVZ Invesco
$24.88 /

-0.67 (-2.62%)

BPTS Biophytis
$8.90 /

+0.05 (+0.56%)

BGNE BeiGene
$385.26 /

+10.94 (+2.92%)

ABCL AbCellera
$19.80 /

+1.03 (+5.49%)

  • 10
    Sep
  • 16
    Jun
  • 12
    Mar
  • 10
    Feb
  • 11
    Dec
  • 11
    Dec
  • 02
    Dec
TTWO Take-Two
$151.89 /

-0.78 (-0.51%)

STT State Street
$87.03 /

-0.9 (-1.02%)

MANU Manchester United
$17.65 /

+0.105 (+0.60%)

IVZ Invesco
$24.88 /

-0.67 (-2.62%)

BGNE BeiGene
$385.26 /

+10.94 (+2.92%)

TTWO Take-Two
$151.89 /

-0.78 (-0.51%)

STT State Street
$87.03 /

-0.9 (-1.02%)

MANU Manchester United
$17.65 /

+0.105 (+0.60%)

ABCL AbCellera
$19.80 /

+1.03 (+5.49%)

TTWO Take-Two
$151.89 /

-0.78 (-0.51%)

STT State Street
$87.03 /

-0.9 (-1.02%)

OPAD Offerpad Solutions
$20.17 /

+7.395 (+57.89%)

MANU Manchester United
$17.65 /

+0.105 (+0.60%)

IVZ Invesco
$24.88 /

-0.67 (-2.62%)

ABCL AbCellera
$19.80 /

+1.03 (+5.49%)

Hot Stocks
AstraZeneca presents results from COAST Phase 2 trial of monalizumab » 07:46
09/17/21
09/17
07:46
09/17/21
07:46
IPHA

Innate Pharma

$5.76 /

+0.26 (+4.73%)

, AZN

AstraZeneca

$56.60 /

+0.14 (+0.25%)

Innate Pharma SA IPHA)…

Innate Pharma SA IPHA) announced that AstraZeneca (AZN) presented results from the randomized COAST Phase 2 trial during the European Society for Medical Oncology Congress 2021 on September 17, 2021. In particular, the results of the interim analysis showed monalizumab in combination with durvalumab improved progression-free survival and objective response rate compared to durvalumab alone in patients with unresectable, Stage III non-small cell lung cancer who had not progressed after concurrent chemoradiation therapy. Monalizumab, Innate's lead partnered asset, is a potentially first-in-class immune checkpoint inhibitor targeting NKG2A receptors expressed on tumor infiltrating cytotoxic CD8+ T cells and NK cells. Based on these results, AstraZeneca informed Innate that it plans to start a registrational study with monalizumab in combination with durvalumab in patients with unresectable, Stage III non-small cell lung cancer.

ShowHide Related Items >><<
IPHA Innate Pharma
$5.76 /

+0.26 (+4.73%)

AZN AstraZeneca
$56.60 /

+0.14 (+0.25%)

IPHA Innate Pharma
$5.76 /

+0.26 (+4.73%)

09/02/21 SVB Leerink
SVB Leerink 'encouraged' by Innate's COAST update, upgrades to Outperform
09/02/21 SVB Leerink
Innate Pharma upgraded to Outperform from Market Perform at SVB Leerink
12/15/20
Fly Intel: Top five analyst downgrades
12/15/20 SVB Leerink
Innate Pharma downgraded to Market Perform at SVB Leerink
AZN AstraZeneca
$56.60 /

+0.14 (+0.25%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
08/12/21 JPMorgan
AstraZeneca resumed with an Overweight at JPMorgan
08/11/21 Goldman Sachs
FibroGen price target lowered to $16 from $22 at Goldman Sachs
08/09/21 Morgan Stanley
AstraZeneca resumed with an Overweight at Morgan Stanley
AZN AstraZeneca
$56.60 /

+0.14 (+0.25%)

AZN AstraZeneca
$56.60 /

+0.14 (+0.25%)

AZN AstraZeneca
$56.60 /

+0.14 (+0.25%)

AZN AstraZeneca
$56.60 /

+0.14 (+0.25%)

Over a week ago
Conference/Events
Citigroup to hold a virtual conference » 04:55
09/10/21
09/10
04:55
09/10/21
04:55
AVRO

Avrobio

$6.44 /

+0.09 (+1.42%)

, ERYP

Erytech Pharma

$6.17 /

-0.08 (-1.28%)

, HRMY

Harmony Biosciences

$37.88 /

-0.66 (-1.71%)

, QURE

uniQure

$35.41 /

+0.73 (+2.10%)

, RCKT

Rocket Pharmaceuticals

$34.47 /

+0.395 (+1.16%)

, XFOR

X4 Pharmaceuticals

$5.01 /

+0.16 (+3.30%)

, IPHA

Innate Pharma

$6.15 /

+0.23 (+3.89%)

, TSHA

Taysha Gene Therapies

$20.12 /

+0.27 (+1.36%)

, NMTR

9 Meters Biopharma

$1.33 /

-0.01 (-0.75%)

, MORF

Morphic

$60.64 /

-0.07 (-0.12%)

, NCNA

NuCana

$2.44 /

+0.025 (+1.04%)

, XCUR

Exicure

$1.40 /

+0.06 (+4.48%)

, CMMB

Chemomab Therapeutics

$14.50 /

-0.38 (-2.55%)

, LABP

Landos Biopharma

$15.43 /

+0.13 (+0.85%)

16th Annual BioPharma…

16th Annual BioPharma Virtual Conference to be held on September 8-10.

ShowHide Related Items >><<
XFOR X4 Pharmaceuticals
$5.01 /

+0.16 (+3.30%)

XCUR Exicure
$1.40 /

+0.06 (+4.48%)

TSHA Taysha Gene Therapies
$20.12 /

+0.27 (+1.36%)

RCKT Rocket Pharmaceuticals
$34.47 /

+0.395 (+1.16%)

QURE uniQure
$35.41 /

+0.73 (+2.10%)

NMTR 9 Meters Biopharma
$1.33 /

-0.01 (-0.75%)

NCNA NuCana
$2.44 /

+0.025 (+1.04%)

MORF Morphic
$60.64 /

-0.07 (-0.12%)

LABP Landos Biopharma
$15.43 /

+0.13 (+0.85%)

IPHA Innate Pharma
$6.15 /

+0.23 (+3.89%)

HRMY Harmony Biosciences
$37.88 /

-0.66 (-1.71%)

ERYP Erytech Pharma
$6.17 /

-0.08 (-1.28%)

CMMB Chemomab Therapeutics
$14.50 /

-0.38 (-2.55%)

AVRO Avrobio
$6.44 /

+0.09 (+1.42%)

AVRO Avrobio
$6.44 /

+0.09 (+1.42%)

06/14/21 BTIG
Avrobio initiated with a Buy at BTIG
05/27/21 Needham
Needham starts Avrobio with a Buy on differentiated platform
05/27/21 Needham
Avrobio initiated with a Buy at Needham
05/04/21 Wells Fargo
Avrobio price target lowered to $36 from $58 at Wells Fargo
ERYP Erytech Pharma
$6.17 /

-0.08 (-1.28%)

HRMY Harmony Biosciences
$37.88 /

-0.66 (-1.71%)

03/29/21 Goldman Sachs
Harmony Biosciences upgraded to Buy from Neutral at Goldman Sachs
09/14/20 Jefferies
Harmony Biosciences initiated with a Buy at Jefferies
09/14/20 Piper Sandler
Harmony Biosciences initiated with an Overweight at Piper Sandler
09/13/20 Goldman Sachs
Harmony Biosciences initiated with a Neutral at Goldman Sachs
QURE uniQure
$35.41 /

+0.73 (+2.10%)

07/27/21 Chardan
uniQure price target lowered to $95 from $100 at Chardan
07/09/21 Chardan
uniQure coverage transferred at Chardan
06/23/21 Chardan
uniQure filing delay could yield better label for EtranaDez, says Chardan
06/16/21 Chardan
uniQure on track for 'powerful' Huntington's catalyst, says Chardan
RCKT Rocket Pharmaceuticals
$34.47 /

+0.395 (+1.16%)

04/01/21 SVB Leerink
Rocket Pharmaceuticals price target raised to $66 from $61 at SVB Leerink
03/22/21 William Blair
Rocket data shows durable impact for PKD, says William Blair
03/10/21 Stifel
Stifel says Bluebird update on AML provides 'some relief' to other LV players
03/01/21 Stifel
Rocket Pharmaceuticals initiated with a Buy at Stifel
XFOR X4 Pharmaceuticals
$5.01 /

+0.16 (+3.30%)

06/11/21 Roth Capital
X4 Pharmaceuticals price target raised to $27 from $23 at Roth Capital
12/17/20 Brookline
X4 Pharmaceuticals initiated with a Buy at Brookline
12/14/20 Roth Capital
New CMO 'another solid addition' to X4 Pharmaceuticals team, says Roth Capital
IPHA Innate Pharma
$6.15 /

+0.23 (+3.89%)

09/02/21 SVB Leerink
SVB Leerink 'encouraged' by Innate's COAST update, upgrades to Outperform
09/02/21 SVB Leerink
Innate Pharma upgraded to Outperform from Market Perform at SVB Leerink
12/15/20
Fly Intel: Top five analyst downgrades
12/15/20 SVB Leerink
Innate Pharma downgraded to Market Perform at SVB Leerink
TSHA Taysha Gene Therapies
$20.12 /

+0.27 (+1.36%)

08/17/21 Chardan
Taysha Gene Therapies price target lowered to $60 from $67.50 at Chardan
07/15/21 Needham
Taysha Gene Therapies initiated with a Buy at Needham
07/09/21 Chardan
Taysha Gene Therapies coverage transferred at Chardan
06/24/21 Truist
Truist starts Taysha Gene Therapies at Buy on potential de-risking events
NMTR 9 Meters Biopharma
$1.33 /

-0.01 (-0.75%)

07/08/21 BMO Capital
9 Meters Biopharma initiated with an Outperform at BMO Capital
06/04/21 Citi
9 Meters Biopharma initiated with a Buy at Citi
05/26/21 Truist
9 Meters' larazotide has potential application in syndrome, says Truist
03/25/21 Brookline
9 Meters Biopharma assumed with a Buy at Brookline
MORF Morphic
$60.64 /

-0.07 (-0.12%)

06/11/21 BMO Capital
Morphic coverage transferred at BMO Capital
03/03/21 SVB Leerink
Protagonist Therapeutics price target raised to $41 from $30 at SVB Leerink
03/01/21 Wells Fargo
Morphic Holding price target raised to $103 from $40 at Wells Fargo
02/02/21 RBC Capital
Morphic Holding price target raised to $50 from $35 at RBC Capital
NCNA NuCana
$2.44 /

+0.025 (+1.04%)

01/15/21 Piper Sandler
Piper sees more evidence that NuCana's NUC-3373 'a better 5-FU'
12/01/20 H.C. Wainwright
NuCana price target lowered to $10 from $15 at H.C. Wainwright
11/24/20 H.C. Wainwright
NuCana price target lowered to $15 from $17 at H.C. Wainwright
10/22/20 Truist
NuCana initiated with a Buy at Truist
XCUR Exicure
$1.40 /

+0.06 (+4.48%)

06/11/21 BMO Capital
Exicure coverage transferred at BMO Capital
12/18/20 BMO Capital
Exicure initiated with an Outperform at BMO Capital
CMMB Chemomab Therapeutics
$14.50 /

-0.38 (-2.55%)

05/26/21 Cantor Fitzgerald
Chemomab Therapeutics initiated with an Overweight at Cantor Fitzgerald
05/07/21 Oppenheimer
Chemomab Therapeutics initiated with an Outperform at Oppenheimer
LABP Landos Biopharma
$15.43 /

+0.13 (+0.85%)

03/01/21 Jefferies
Landos Biopharma initiated with a Buy at Jefferies
03/01/21 JPMorgan
Landos Biopharma initiated with a Neutral at JPMorgan
03/01/21 Raymond James
Landos Biopharma initiated with an Outperform at Raymond James
03/01/21 SVB Leerink
Landos Biopharma initiated with an Outperform at SVB Leerink
XFOR X4 Pharmaceuticals
$5.01 /

+0.16 (+3.30%)

XCUR Exicure
$1.40 /

+0.06 (+4.48%)

TSHA Taysha Gene Therapies
$20.12 /

+0.27 (+1.36%)

RCKT Rocket Pharmaceuticals
$34.47 /

+0.395 (+1.16%)

QURE uniQure
$35.41 /

+0.73 (+2.10%)

NMTR 9 Meters Biopharma
$1.33 /

-0.01 (-0.75%)

NCNA NuCana
$2.44 /

+0.025 (+1.04%)

MORF Morphic
$60.64 /

-0.07 (-0.12%)

LABP Landos Biopharma
$15.43 /

+0.13 (+0.85%)

HRMY Harmony Biosciences
$37.88 /

-0.66 (-1.71%)

CMMB Chemomab Therapeutics
$14.50 /

-0.38 (-2.55%)

AVRO Avrobio
$6.44 /

+0.09 (+1.42%)

  • 31
    Mar
  • 03
    Mar
  • 04
    Feb
  • 11
    Dec
  • 10
    Dec
  • 20
    Nov
  • 24
    Sep
  • 17
    Sep
XCUR Exicure
$1.40 /

+0.06 (+4.48%)

RCKT Rocket Pharmaceuticals
$34.47 /

+0.395 (+1.16%)

QURE uniQure
$35.41 /

+0.73 (+2.10%)

NMTR 9 Meters Biopharma
$1.33 /

-0.01 (-0.75%)

ERYP Erytech Pharma
$6.17 /

-0.08 (-1.28%)

CMMB Chemomab Therapeutics
$14.50 /

-0.38 (-2.55%)

XFOR X4 Pharmaceuticals
$5.01 /

+0.16 (+3.30%)

MORF Morphic
$60.64 /

-0.07 (-0.12%)

ERYP Erytech Pharma
$6.17 /

-0.08 (-1.28%)

Conference/Events
Citigroup to hold a virtual conference » 04:55
09/09/21
09/09
04:55
09/09/21
04:55
AVRO

Avrobio

$6.35 /

-0.01 (-0.16%)

, ERYP

Erytech Pharma

$6.25 /

-0.2 (-3.10%)

, HRMY

Harmony Biosciences

$38.44 /

+0.64 (+1.69%)

, QURE

uniQure

$34.68 /

-0.24 (-0.69%)

, RCKT

Rocket Pharmaceuticals

$34.07 /

-1.09 (-3.10%)

, XFOR

X4 Pharmaceuticals

$4.85 /

-0.14 (-2.81%)

, IPHA

Innate Pharma

$5.75 /

+0.1 (+1.77%)

, TSHA

Taysha Gene Therapies

$19.76 /

-1.81 (-8.39%)

, NMTR

9 Meters Biopharma

$1.34 /

+ (+0.00%)

, MORF

Morphic

$60.65 /

-3.715 (-5.77%)

, NCNA

NuCana

$2.42 /

-0.125 (-4.92%)

, XCUR

Exicure

$1.34 /

-0.02 (-1.48%)

, CMMB

Chemomab Therapeutics

$14.85 /

-0.15 (-1.00%)

, LABP

Landos Biopharma

$15.30 /

+0.88 (+6.10%)

16th Annual BioPharma…

16th Annual BioPharma Virtual Conference to be held on September 8-10.

ShowHide Related Items >><<
XFOR X4 Pharmaceuticals
$4.85 /

-0.14 (-2.81%)

XCUR Exicure
$1.34 /

-0.02 (-1.48%)

TSHA Taysha Gene Therapies
$19.76 /

-1.81 (-8.39%)

RCKT Rocket Pharmaceuticals
$34.07 /

-1.09 (-3.10%)

QURE uniQure
$34.68 /

-0.24 (-0.69%)

NMTR 9 Meters Biopharma
$1.34 /

+ (+0.00%)

NCNA NuCana
$2.42 /

-0.125 (-4.92%)

MORF Morphic
$60.65 /

-3.715 (-5.77%)

LABP Landos Biopharma
$15.30 /

+0.88 (+6.10%)

IPHA Innate Pharma
$5.75 /

+0.1 (+1.77%)

HRMY Harmony Biosciences
$38.44 /

+0.64 (+1.69%)

ERYP Erytech Pharma
$6.25 /

-0.2 (-3.10%)

CMMB Chemomab Therapeutics
$14.85 /

-0.15 (-1.00%)

AVRO Avrobio
$6.35 /

-0.01 (-0.16%)

AVRO Avrobio
$6.35 /

-0.01 (-0.16%)

06/14/21 BTIG
Avrobio initiated with a Buy at BTIG
05/27/21 Needham
Needham starts Avrobio with a Buy on differentiated platform
05/27/21 Needham
Avrobio initiated with a Buy at Needham
05/04/21 Wells Fargo
Avrobio price target lowered to $36 from $58 at Wells Fargo
ERYP Erytech Pharma
$6.25 /

-0.2 (-3.10%)

HRMY Harmony Biosciences
$38.44 /

+0.64 (+1.69%)

03/29/21 Goldman Sachs
Harmony Biosciences upgraded to Buy from Neutral at Goldman Sachs
09/14/20 Jefferies
Harmony Biosciences initiated with a Buy at Jefferies
09/14/20 Piper Sandler
Harmony Biosciences initiated with an Overweight at Piper Sandler
09/13/20 Goldman Sachs
Harmony Biosciences initiated with a Neutral at Goldman Sachs
QURE uniQure
$34.68 /

-0.24 (-0.69%)

07/27/21 Chardan
uniQure price target lowered to $95 from $100 at Chardan
07/09/21 Chardan
uniQure coverage transferred at Chardan
06/23/21 Chardan
uniQure filing delay could yield better label for EtranaDez, says Chardan
06/16/21 Chardan
uniQure on track for 'powerful' Huntington's catalyst, says Chardan
RCKT Rocket Pharmaceuticals
$34.07 /

-1.09 (-3.10%)

04/01/21 SVB Leerink
Rocket Pharmaceuticals price target raised to $66 from $61 at SVB Leerink
03/22/21 William Blair
Rocket data shows durable impact for PKD, says William Blair
03/10/21 Stifel
Stifel says Bluebird update on AML provides 'some relief' to other LV players
03/01/21 Stifel
Rocket Pharmaceuticals initiated with a Buy at Stifel
XFOR X4 Pharmaceuticals
$4.85 /

-0.14 (-2.81%)

06/11/21 Roth Capital
X4 Pharmaceuticals price target raised to $27 from $23 at Roth Capital
12/17/20 Brookline
X4 Pharmaceuticals initiated with a Buy at Brookline
12/14/20 Roth Capital
New CMO 'another solid addition' to X4 Pharmaceuticals team, says Roth Capital
IPHA Innate Pharma
$5.75 /

+0.1 (+1.77%)

09/02/21 SVB Leerink
SVB Leerink 'encouraged' by Innate's COAST update, upgrades to Outperform
09/02/21 SVB Leerink
Innate Pharma upgraded to Outperform from Market Perform at SVB Leerink
12/15/20
Fly Intel: Top five analyst downgrades
12/15/20 SVB Leerink
Innate Pharma downgraded to Market Perform at SVB Leerink
TSHA Taysha Gene Therapies
$19.76 /

-1.81 (-8.39%)

08/17/21 Chardan
Taysha Gene Therapies price target lowered to $60 from $67.50 at Chardan
07/15/21 Needham
Taysha Gene Therapies initiated with a Buy at Needham
07/09/21 Chardan
Taysha Gene Therapies coverage transferred at Chardan
06/24/21 Truist
Truist starts Taysha Gene Therapies at Buy on potential de-risking events
NMTR 9 Meters Biopharma
$1.34 /

+ (+0.00%)

07/08/21 BMO Capital
9 Meters Biopharma initiated with an Outperform at BMO Capital
06/04/21 Citi
9 Meters Biopharma initiated with a Buy at Citi
05/26/21 Truist
9 Meters' larazotide has potential application in syndrome, says Truist
03/25/21 Brookline
9 Meters Biopharma assumed with a Buy at Brookline
MORF Morphic
$60.65 /

-3.715 (-5.77%)

06/11/21 BMO Capital
Morphic coverage transferred at BMO Capital
03/03/21 SVB Leerink
Protagonist Therapeutics price target raised to $41 from $30 at SVB Leerink
03/01/21 Wells Fargo
Morphic Holding price target raised to $103 from $40 at Wells Fargo
02/02/21 RBC Capital
Morphic Holding price target raised to $50 from $35 at RBC Capital
NCNA NuCana
$2.42 /

-0.125 (-4.92%)

01/15/21 Piper Sandler
Piper sees more evidence that NuCana's NUC-3373 'a better 5-FU'
12/01/20 H.C. Wainwright
NuCana price target lowered to $10 from $15 at H.C. Wainwright
11/24/20 H.C. Wainwright
NuCana price target lowered to $15 from $17 at H.C. Wainwright
10/22/20 Truist
NuCana initiated with a Buy at Truist
XCUR Exicure
$1.34 /

-0.02 (-1.48%)

06/11/21 BMO Capital
Exicure coverage transferred at BMO Capital
12/18/20 BMO Capital
Exicure initiated with an Outperform at BMO Capital
CMMB Chemomab Therapeutics
$14.85 /

-0.15 (-1.00%)

05/26/21 Cantor Fitzgerald
Chemomab Therapeutics initiated with an Overweight at Cantor Fitzgerald
05/07/21 Oppenheimer
Chemomab Therapeutics initiated with an Outperform at Oppenheimer
LABP Landos Biopharma
$15.30 /

+0.88 (+6.10%)

03/01/21 Jefferies
Landos Biopharma initiated with a Buy at Jefferies
03/01/21 JPMorgan
Landos Biopharma initiated with a Neutral at JPMorgan
03/01/21 Raymond James
Landos Biopharma initiated with an Outperform at Raymond James
03/01/21 SVB Leerink
Landos Biopharma initiated with an Outperform at SVB Leerink
XFOR X4 Pharmaceuticals
$4.85 /

-0.14 (-2.81%)

XCUR Exicure
$1.34 /

-0.02 (-1.48%)

TSHA Taysha Gene Therapies
$19.76 /

-1.81 (-8.39%)

RCKT Rocket Pharmaceuticals
$34.07 /

-1.09 (-3.10%)

QURE uniQure
$34.68 /

-0.24 (-0.69%)

NMTR 9 Meters Biopharma
$1.34 /

+ (+0.00%)

NCNA NuCana
$2.42 /

-0.125 (-4.92%)

MORF Morphic
$60.65 /

-3.715 (-5.77%)

LABP Landos Biopharma
$15.30 /

+0.88 (+6.10%)

HRMY Harmony Biosciences
$38.44 /

+0.64 (+1.69%)

CMMB Chemomab Therapeutics
$14.85 /

-0.15 (-1.00%)

AVRO Avrobio
$6.35 /

-0.01 (-0.16%)

  • 31
    Mar
  • 03
    Mar
  • 04
    Feb
  • 11
    Dec
  • 10
    Dec
  • 20
    Nov
  • 24
    Sep
  • 17
    Sep
XCUR Exicure
$1.34 /

-0.02 (-1.48%)

RCKT Rocket Pharmaceuticals
$34.07 /

-1.09 (-3.10%)

QURE uniQure
$34.68 /

-0.24 (-0.69%)

NMTR 9 Meters Biopharma
$1.34 /

+ (+0.00%)

ERYP Erytech Pharma
$6.25 /

-0.2 (-3.10%)

CMMB Chemomab Therapeutics
$14.85 /

-0.15 (-1.00%)

XFOR X4 Pharmaceuticals
$4.85 /

-0.14 (-2.81%)

MORF Morphic
$60.65 /

-3.715 (-5.77%)

ERYP Erytech Pharma
$6.25 /

-0.2 (-3.10%)

Conference/Events
Citigroup to hold a virtual conference » 17:24
09/08/21
09/08
17:24
09/08/21
17:24
AVRO

Avrobio

$6.35 /

-0.01 (-0.16%)

, ERYP

Erytech Pharma

$6.25 /

-0.2 (-3.10%)

, HRMY

Harmony Biosciences

$38.44 /

+0.64 (+1.69%)

, QURE

uniQure

$34.68 /

-0.24 (-0.69%)

, RCKT

Rocket Pharmaceuticals

$34.07 /

-1.09 (-3.10%)

, XFOR

X4 Pharmaceuticals

$4.85 /

-0.14 (-2.81%)

, IPHA

Innate Pharma

$5.75 /

+0.1 (+1.77%)

, TSHA

Taysha Gene Therapies

$19.76 /

-1.81 (-8.39%)

, NMTR

9 Meters Biopharma

$1.34 /

+ (+0.00%)

, MORF

Morphic

$60.65 /

-3.715 (-5.77%)

, NCNA

NuCana

$2.42 /

-0.125 (-4.92%)

, XCUR

Exicure

$1.34 /

-0.02 (-1.48%)

, CMMB

Chemomab Therapeutics

$14.85 /

-0.15 (-1.00%)

, LABP

Landos Biopharma

$15.30 /

+0.88 (+6.10%)

16th Annual BioPharma…

16th Annual BioPharma Virtual Conference to be held on September 8-10.

ShowHide Related Items >><<
XFOR X4 Pharmaceuticals
$4.85 /

-0.14 (-2.81%)

XCUR Exicure
$1.34 /

-0.02 (-1.48%)

TSHA Taysha Gene Therapies
$19.76 /

-1.81 (-8.39%)

RCKT Rocket Pharmaceuticals
$34.07 /

-1.09 (-3.10%)

QURE uniQure
$34.68 /

-0.24 (-0.69%)

NMTR 9 Meters Biopharma
$1.34 /

+ (+0.00%)

NCNA NuCana
$2.42 /

-0.125 (-4.92%)

MORF Morphic
$60.65 /

-3.715 (-5.77%)

LABP Landos Biopharma
$15.30 /

+0.88 (+6.10%)

IPHA Innate Pharma
$5.75 /

+0.1 (+1.77%)

HRMY Harmony Biosciences
$38.44 /

+0.64 (+1.69%)

ERYP Erytech Pharma
$6.25 /

-0.2 (-3.10%)

CMMB Chemomab Therapeutics
$14.85 /

-0.15 (-1.00%)

AVRO Avrobio
$6.35 /

-0.01 (-0.16%)

AVRO Avrobio
$6.35 /

-0.01 (-0.16%)

06/14/21 BTIG
Avrobio initiated with a Buy at BTIG
05/27/21 Needham
Needham starts Avrobio with a Buy on differentiated platform
05/27/21 Needham
Avrobio initiated with a Buy at Needham
05/04/21 Wells Fargo
Avrobio price target lowered to $36 from $58 at Wells Fargo
ERYP Erytech Pharma
$6.25 /

-0.2 (-3.10%)

HRMY Harmony Biosciences
$38.44 /

+0.64 (+1.69%)

03/29/21 Goldman Sachs
Harmony Biosciences upgraded to Buy from Neutral at Goldman Sachs
09/14/20 Jefferies
Harmony Biosciences initiated with a Buy at Jefferies
09/14/20 Piper Sandler
Harmony Biosciences initiated with an Overweight at Piper Sandler
09/13/20 Goldman Sachs
Harmony Biosciences initiated with a Neutral at Goldman Sachs
QURE uniQure
$34.68 /

-0.24 (-0.69%)

07/27/21 Chardan
uniQure price target lowered to $95 from $100 at Chardan
07/09/21 Chardan
uniQure coverage transferred at Chardan
06/23/21 Chardan
uniQure filing delay could yield better label for EtranaDez, says Chardan
06/16/21 Chardan
uniQure on track for 'powerful' Huntington's catalyst, says Chardan
RCKT Rocket Pharmaceuticals
$34.07 /

-1.09 (-3.10%)

04/01/21 SVB Leerink
Rocket Pharmaceuticals price target raised to $66 from $61 at SVB Leerink
03/22/21 William Blair
Rocket data shows durable impact for PKD, says William Blair
03/10/21 Stifel
Stifel says Bluebird update on AML provides 'some relief' to other LV players
03/01/21 Stifel
Rocket Pharmaceuticals initiated with a Buy at Stifel
XFOR X4 Pharmaceuticals
$4.85 /

-0.14 (-2.81%)

06/11/21 Roth Capital
X4 Pharmaceuticals price target raised to $27 from $23 at Roth Capital
12/17/20 Brookline
X4 Pharmaceuticals initiated with a Buy at Brookline
12/14/20 Roth Capital
New CMO 'another solid addition' to X4 Pharmaceuticals team, says Roth Capital
IPHA Innate Pharma
$5.75 /

+0.1 (+1.77%)

09/02/21 SVB Leerink
SVB Leerink 'encouraged' by Innate's COAST update, upgrades to Outperform
09/02/21 SVB Leerink
Innate Pharma upgraded to Outperform from Market Perform at SVB Leerink
12/15/20
Fly Intel: Top five analyst downgrades
12/15/20 SVB Leerink
Innate Pharma downgraded to Market Perform at SVB Leerink
TSHA Taysha Gene Therapies
$19.76 /

-1.81 (-8.39%)

08/17/21 Chardan
Taysha Gene Therapies price target lowered to $60 from $67.50 at Chardan
07/15/21 Needham
Taysha Gene Therapies initiated with a Buy at Needham
07/09/21 Chardan
Taysha Gene Therapies coverage transferred at Chardan
06/24/21 Truist
Truist starts Taysha Gene Therapies at Buy on potential de-risking events
NMTR 9 Meters Biopharma
$1.34 /

+ (+0.00%)

07/08/21 BMO Capital
9 Meters Biopharma initiated with an Outperform at BMO Capital
06/04/21 Citi
9 Meters Biopharma initiated with a Buy at Citi
05/26/21 Truist
9 Meters' larazotide has potential application in syndrome, says Truist
03/25/21 Brookline
9 Meters Biopharma assumed with a Buy at Brookline
MORF Morphic
$60.65 /

-3.715 (-5.77%)

06/11/21 BMO Capital
Morphic coverage transferred at BMO Capital
03/03/21 SVB Leerink
Protagonist Therapeutics price target raised to $41 from $30 at SVB Leerink
03/01/21 Wells Fargo
Morphic Holding price target raised to $103 from $40 at Wells Fargo
02/02/21 RBC Capital
Morphic Holding price target raised to $50 from $35 at RBC Capital
NCNA NuCana
$2.42 /

-0.125 (-4.92%)

01/15/21 Piper Sandler
Piper sees more evidence that NuCana's NUC-3373 'a better 5-FU'
12/01/20 H.C. Wainwright
NuCana price target lowered to $10 from $15 at H.C. Wainwright
11/24/20 H.C. Wainwright
NuCana price target lowered to $15 from $17 at H.C. Wainwright
10/22/20 Truist
NuCana initiated with a Buy at Truist
XCUR Exicure
$1.34 /

-0.02 (-1.48%)

06/11/21 BMO Capital
Exicure coverage transferred at BMO Capital
12/18/20 BMO Capital
Exicure initiated with an Outperform at BMO Capital
CMMB Chemomab Therapeutics
$14.85 /

-0.15 (-1.00%)

05/26/21 Cantor Fitzgerald
Chemomab Therapeutics initiated with an Overweight at Cantor Fitzgerald
05/07/21 Oppenheimer
Chemomab Therapeutics initiated with an Outperform at Oppenheimer
LABP Landos Biopharma
$15.30 /

+0.88 (+6.10%)

03/01/21 Jefferies
Landos Biopharma initiated with a Buy at Jefferies
03/01/21 JPMorgan
Landos Biopharma initiated with a Neutral at JPMorgan
03/01/21 Raymond James
Landos Biopharma initiated with an Outperform at Raymond James
03/01/21 SVB Leerink
Landos Biopharma initiated with an Outperform at SVB Leerink
XFOR X4 Pharmaceuticals
$4.85 /

-0.14 (-2.81%)

XCUR Exicure
$1.34 /

-0.02 (-1.48%)

TSHA Taysha Gene Therapies
$19.76 /

-1.81 (-8.39%)

RCKT Rocket Pharmaceuticals
$34.07 /

-1.09 (-3.10%)

QURE uniQure
$34.68 /

-0.24 (-0.69%)

NMTR 9 Meters Biopharma
$1.34 /

+ (+0.00%)

NCNA NuCana
$2.42 /

-0.125 (-4.92%)

MORF Morphic
$60.65 /

-3.715 (-5.77%)

LABP Landos Biopharma
$15.30 /

+0.88 (+6.10%)

HRMY Harmony Biosciences
$38.44 /

+0.64 (+1.69%)

CMMB Chemomab Therapeutics
$14.85 /

-0.15 (-1.00%)

AVRO Avrobio
$6.35 /

-0.01 (-0.16%)

  • 31
    Mar
  • 03
    Mar
  • 04
    Feb
  • 11
    Dec
  • 10
    Dec
  • 20
    Nov
  • 24
    Sep
  • 17
    Sep
XCUR Exicure
$1.34 /

-0.02 (-1.48%)

RCKT Rocket Pharmaceuticals
$34.07 /

-1.09 (-3.10%)

QURE uniQure
$34.68 /

-0.24 (-0.69%)

NMTR 9 Meters Biopharma
$1.34 /

+ (+0.00%)

ERYP Erytech Pharma
$6.25 /

-0.2 (-3.10%)

CMMB Chemomab Therapeutics
$14.85 /

-0.15 (-1.00%)

XFOR X4 Pharmaceuticals
$4.85 /

-0.14 (-2.81%)

MORF Morphic
$60.65 /

-3.715 (-5.77%)

ERYP Erytech Pharma
$6.25 /

-0.2 (-3.10%)

Upgrade
SVB Leerink 'encouraged' by Innate's COAST update, upgrades to Outperform » 16:34
09/02/21
09/02
16:34
09/02/21
16:34
IPHA

Innate Pharma

$4.13 /

+0.5 (+13.77%)

SVB Leerink analyst Daina…

SVB Leerink analyst Daina Graybosch upgraded Innate Pharma to Outperform from Market Perform with a $7 price target. The analyst was "encouraged" by the language in a recent press release from Innate and partner AstraZeneca (AZN) announcing Phase 2 COAST data. Graybosch said a "strong signal" would de-risk a large opportunity for monalizumab and change the narrative around Innate.

ShowHide Related Items >><<
IPHA Innate Pharma
$4.13 /

+0.5 (+13.77%)

IPHA Innate Pharma
$4.13 /

+0.5 (+13.77%)

09/02/21 SVB Leerink
Innate Pharma upgraded to Outperform from Market Perform at SVB Leerink
12/15/20
Fly Intel: Top five analyst downgrades
12/15/20 SVB Leerink
Innate Pharma downgraded to Market Perform at SVB Leerink
12/15/20 SVB Leerink
Innate Pharma downgraded to Market Perform from Outperform at SVB Leerink
Upgrade
Innate Pharma upgraded to Outperform from Market Perform at SVB Leerink » 16:09
09/02/21
09/02
16:09
09/02/21
16:09
IPHA

Innate Pharma

$4.19 /

+0.56 (+15.43%)

SVB Leerink analyst Daina…

SVB Leerink analyst Daina Graybosch upgraded Innate Pharma to Outperform from Market Perform.

ShowHide Related Items >><<
IPHA Innate Pharma
$4.19 /

+0.56 (+15.43%)

IPHA Innate Pharma
$4.19 /

+0.56 (+15.43%)

12/15/20
Fly Intel: Top five analyst downgrades
12/15/20 SVB Leerink
Innate Pharma downgraded to Market Perform at SVB Leerink
12/15/20 SVB Leerink
Innate Pharma downgraded to Market Perform from Outperform at SVB Leerink
12/14/20 H.C. Wainwright
Innate Pharma price target lowered to $11.50 from $13 at H.C. Wainwright

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.